The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response.
Ebola
LARGE
Lassa fever
Lassa virus
bioinformatics
diagnostic tools
genomic surveillance
infectious disease
pandemic preemption
pandemic response
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
13 08 2021
13 08 2021
Historique:
received:
07
06
2021
revised:
21
07
2021
accepted:
21
07
2021
entrez:
28
8
2021
pubmed:
29
8
2021
medline:
15
12
2021
Statut:
epublish
Résumé
While investigating a signal of adaptive evolution in humans at the gene LARGE, we encountered an intriguing finding by Dr. Stefan Kunz that the gene plays a critical role in Lassa virus binding and entry. This led us to pursue field work to test our hypothesis that natural selection acting on LARGE-detected in the Yoruba population of Nigeria-conferred resistance to Lassa Fever in some West African populations. As we delved further, we conjectured that the "emerging" nature of recently discovered diseases like Lassa fever is related to a newfound capacity for detection, rather than a novel viral presence, and that humans have in fact been exposed to the viruses that cause such diseases for much longer than previously suspected. Dr. Stefan Kunz's critical efforts not only laid the groundwork for this discovery, but also inspired and catalyzed a series of events that birthed Sentinel, an ambitious and large-scale pandemic prevention effort in West Africa. Sentinel aims to detect and characterize deadly pathogens before they spread across the globe, through implementation of its three fundamental pillars: Detect, Connect, and Empower. More specifically, Sentinel is designed to detect known and novel infections rapidly, connect and share information in real time to identify emerging threats, and empower the public health community to improve pandemic preparedness and response anywhere in the world. We are proud to dedicate this work to Stefan Kunz, and eagerly invite new collaborators, experts, and others to join us in our efforts.
Identifiants
pubmed: 34452470
pii: v13081605
doi: 10.3390/v13081605
pmc: PMC8402630
pii:
doi:
Substances chimiques
Receptors, Virus
0
LARGE1 protein, human
EC 2.4.1.-
N-Acetylglucosaminyltransferases
EC 2.4.1.-
Types de publication
Consensus Development Conference
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States
Références
Emerg Infect Dis. 2005 Oct;11(10):1642-4
pubmed: 16355508
J Virol. 2005 Nov;79(22):14282-96
pubmed: 16254363
Nature. 2020 Jun;582(7811):277-282
pubmed: 32349121
Nature. 2007 Oct 18;449(7164):913-8
pubmed: 17943131
Am J Trop Med Hyg. 1970 Jul;19(4):695-6
pubmed: 4987549
J Virol. 2005 May;79(10):5979-87
pubmed: 15857984
Cell Host Microbe. 2017 Mar 8;21(3):367-375
pubmed: 28238624
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Cell Rep. 2018 May 8;23(6):1806-1816
pubmed: 29742435
Science. 2012 Nov 9;338(6108):750-2
pubmed: 23139320
Science. 2018 Apr 27;360(6387):444-448
pubmed: 29700266
Lancet. 1995 Aug 19;346(8973):472-5
pubmed: 7637481
Cell. 2016 Nov 3;167(4):1088-1098.e6
pubmed: 27814506
N Engl J Med. 2014 Oct 9;371(15):1418-25
pubmed: 24738640
Cell. 2015 Aug 13;162(4):738-50
pubmed: 26276630
PLoS Negl Trop Dis. 2012;6(9):e1839
pubmed: 23029594